Related references
Note: Only part of the references are listed.Development and Preclinical Evaluation of99mTc-and186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors
George Makris et al.
MOLECULAR IMAGING AND BIOLOGY (2021)
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
Christina Baun et al.
MOLECULES (2020)
Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors
Lucia Baratto et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
Alessandra Boschi et al.
DRUG DISCOVERY TODAY (2018)
Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [Cu-64]-DOTHA(2)-PEG-RM26
Nematallah Mansour et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model
Svetlana N. Rylova et al.
PLOS ONE (2018)
Peptide Receptor Radionuclide Therapy: An Overview
Ashutosh Dash et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging
Eleni Gourni et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
Gesche Wieser et al.
THERANOSTICS (2014)
Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
Rebecca A. Dumont et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Cu-64-Labeled Lactam Bridge-Cyclized α-MSH Peptides for PET Imaging of Melanoma
Haixun Guo et al.
MOLECULAR PHARMACEUTICS (2012)
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
18F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors
Michael Honer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET of Somatostatin Receptor-Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
Melpomeni Fani et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
F-18-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging
Min Yang et al.
THERANOSTICS (2011)
Peptides and Peptide Hormones for Molecular Imaging and Disease Diagnosis
Seulki Lee et al.
CHEMICAL REVIEWS (2010)
Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model
Stephanie R. Lane et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)
Monica Shokeen et al.
ACCOUNTS OF CHEMICAL RESEARCH (2009)
Bombesin receptor antagonists may be preferable to agonists for tumor targeting
Renzo Cescato et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs:: Side-by-side comparison of the CB-TE2A and DOTA chelation systems
Jered C. Garrison et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues
Adam F. Prasanphanich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver
LA Bass et al.
BIOCONJUGATE CHEMISTRY (2000)
Share Paper
